ARCHIVES

GAO: FDA Data On Drug Shortages Inadequate

This article is from The Cancer Letter archive.

Vol. 40 No. 08 | February 21, 2014

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

NCI-Approved Clinical Trials

December 29, 2006

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000